US Patent 11913013 Chimpanzee adenoviral vector-based filovirus vaccines
Patent 11913013 was granted and assigned to Sabin Vaccine Institute on February, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11913013 Chimpanzee adenoviral vector-based filovirus vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
